Growth Metrics

Pfizer (PFE) Goodwill (2016 - 2025)

Pfizer (PFE) has disclosed Goodwill for 17 consecutive years, with $71.3 billion as the latest value for Q4 2025.

  • Quarterly Goodwill rose 3.99% to $71.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.3 billion through Dec 2025, up 3.99% year-over-year, with the annual reading at $71.3 billion for FY2025, 3.99% up from the prior year.
  • Goodwill for Q4 2025 was $71.3 billion at Pfizer, up from $69.1 billion in the prior quarter.
  • The five-year high for Goodwill was $71.3 billion in Q4 2025, with the low at $49.2 billion in Q4 2021.
  • Average Goodwill over 5 years is $58.7 billion, with a median of $51.5 billion recorded in 2023.
  • The sharpest move saw Goodwill fell 17.38% in 2021, then surged 34.62% in 2024.
  • Over 5 years, Goodwill stood at $49.2 billion in 2021, then rose by 4.4% to $51.4 billion in 2022, then skyrocketed by 31.94% to $67.8 billion in 2023, then increased by 1.1% to $68.5 billion in 2024, then grew by 3.99% to $71.3 billion in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $71.3 billion, $69.1 billion, and $69.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.